knowledge -WSS

knowledge

author：explore 2025-10-02 23:31:05 - browse：79783

Smartphone & medicine illustration — Alex Hogan/STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system.

In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022. The data, which take into account health care utilization before and after people used the apps, have been presented to policymakers considering how to cover novel digital health products and shown to lawmakers considering federal legislation that would require Medicare coverage for prescription apps.

Pear, which filed for bankruptcy earlier this year, was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Pear’s reSET was the first such app cleared by the FDA in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Medicare Advantage beneficiaries sue Humana over algorithm use

entertainment

WSS

Health tech startups drop sharply from 2021 highs

Albert Bourla of Pfizer: worst biopharma CEO of 2023

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Did you have Obamacare on your GOP debate bingo card?

Menendez indictment could see pharma lose a key ally

Christmas in the PICU brings some surprising joy

focus

knowledge

focus

Affirmative action in medical school literally saved lives

Christmas in the PICU brings some surprising joy

Walensky prepares to leave CDC — and Congress — behind

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Medical leaders decry Supreme Court decision on affirmative action

Grail spinoff by Illumina should end disastrous merger attempt

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Inequities make cancer less preventable for women: report

Activists slam private health insurers over coverage restrictions

STAT Virtual Event: How to Increase Diversity in Clinical Trials

explore

Mindstrong's demise and the future of mental health care

Would Medicare drug price negotiations stall in a shutdown?

Biogen shutters digital health group, ends Apple study, in cost cutting move

Would Medicare drug price negotiations stall in a shutdown?

Address the ethical violations that led to 'Three Identical Strangers'

Did you have Obamacare on your GOP debate bingo card?

Wikipedia

entertainment

hotspot

Wikipedia